N-0385 | Interleukin Related interleukin-related.com

Product Name :
N-0385

Search keywords :
Transmembrane Protease Serine 2

drugId :
null

Target Vo:
Transmembrane protease serine 2

Target Vo Short Name :
TMPRSS2

Moa_Name:
Transmembrane protease serine 2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
The University Of British Columbia

Active Company_Name :
The University Of British Columbia

Active Indication_Name:
Coronavirus Disease 2019 (COVID-19)

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
IGF1 Receptor Antibody
GAPDH Antibody (HRP) (YA874)
RANKL/CD254 Antibody: RANKL/CD254 Antibody is an unconjugated, approximately 35 kDa, rabbit-derived, anti-RANKL/CD254 polyclonal antibody. RANKL/CD254 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, and predicted: rat, dog background without labeling.

Author: Interleukin Related

Related Posts